Marijuana Investors: Why Aurora Cannabis (TSX:ACB) May Actually Be the Cheapest Stock on the TSX Index

After a “weak” fourth quarter, Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) looks like a play that could make investors rich come 2020 and beyond.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

You’ve probably heard of value traps — seemingly cheap stocks with ridiculously low valuation metrics that are anything but. Troubled businesses with decaying fundamentals can appear cheap, but relative to their growth prospects, they may be absurdly expensive and leave investors at risk of substantial downside.

What you may not have heard of are stocks that seem ridiculously expensive but are actually screaming bargains. I’m not sure if there’s a word dedicated for such stocks, but let’s call it a fundamental bear trap, even though the term bear trap actually denotes a technical pattern.

One such stock that I believe is an expensive-looking stock that is actually severely undervalued given its growth prospects is Aurora Cannabis (TSX:ACB)(NYSE:ACB).

The Edmonton-based cannabis kingpin is a rapidly growing company that few investors (or analysts) can get a firm grasp of. The industry is hazy and the valuation is out of this world, but the growth potential is also just as unfathomable.

While pot stocks aren’t everybody’s cup of tea, I do believe that such names that seem way overvalued, like Aurora Cannabis and its 43.6 times sales multiple, may be suitable for value investors with long-term investment horizons, even though pot stocks have always been a trader’s playground.

A weak quarter — or was it?

At the time of writing, Aurora is down by over 10% in after-hours trading following the release of its fourth-quarter results that fell short of expectations on the revenue front.

Revenues rose to $98.9 million, missing the Street consensus of $108.3 million. Although sales were up triple digits on a year-over-year basis, investors were expecting a bit too much from the cannabis kingpin that’s on the right track when it comes to the pathway to profitability.

Management seems optimistic that Aurora is going to be profitable in 2020, but given the moves, many investors seem to think it’s all smoke and mirrors.

In any case, the quarter was more mixed than the after-hours move in the stock would suggest. The average net selling price of cannabis continues to fall, and while the stock will continue to be a roller-coaster ride over the next few weeks, Aurora stock is a strong buy because it looks cheap at $8 and change relative to its very encouraging growth prospects and overlooked progress made in the latest quarter.

Yes, there’s uncertainty on the horizon, but as the industry matures, I do see Aurora as one of the market leaders that’ll command triple-digit growth over the medium term and high double-digit growth over the extremely long run, as the international taboo on cannabis slowly but surely fades.

After shedding nearly half its value, Aurora Cannabis is finally a value investment and not a speculation that Fools should feel confident buying on the post-earnings dip.

Foolish takeaway

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »